Bloomage BioTechnology Corporation Limited, entered into a property rights transaction contract to acquire 51% of Beijing Yierkang Bioengineering Co., Ltd., for CNY 233 million.

Bloomage BioTechnology Corporation Limited (SHSE:688363), entered into a property rights transaction contract to acquire 51% of Beijing Yierkang Bioengineering Co., Ltd., for CNY 233 million on April 15, 2022. As of November 30, 2021, Beijing Yierkang Bioengineering's total assets were CNY 113 million.